Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
108M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
+36.8M
-
Total reported value, excl. options
-
$2.05B
-
Value change
-
+$2.05B
-
Put/Call ratio
-
4.72
-
Number of buys
-
138
-
Price
-
$55.60
Significant Holders of GoodRx Holdings, Inc. - Class A Common Stock (GDRX) as of Q3 2020
144 filings reported holding GDRX - GoodRx Holdings, Inc. - Class A Common Stock as of Q3 2020.
GoodRx Holdings, Inc. - Class A Common Stock (GDRX) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 108M outstanding shares and own 34.23% of the company stock.
Largest 10 shareholders include Silver Lake Group, L.L.C. (3.03M shares), VANGUARD GROUP INC (2.41M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.25M shares), FMR LLC (1.89M shares), LIGHT STREET CAPITAL MANAGEMENT, LLC (1.78M shares), MORGAN STANLEY (1.65M shares), BAMCO INC /NY/ (1.56M shares), Capital International Investors (1.5M shares), TIGER GLOBAL MANAGEMENT LLC (1.4M shares), and Capital World Investors (1.3M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.